Company Filing History:
Years Active: 1990-1998
Title: The Innovative Contributions of Alfredo Guerrato
Introduction
Alfredo Guerrato, an inventive mind hailing from Trissino, Italy, has made significant strides in the field of pharmaceuticals through his innovative work and patent contributions. With a total of two patents to his name, Guerrato has exemplified dedication and ingenuity in the development of important chemical processes that aid in creating essential medicinal compounds.
Latest Patents
Guerrato's latest patents focus on processes that enhance the preparation of critical pharmaceutical agents. The first patent details a "Process for the preparation of furosemide," a diuretic that plays a vital role in medical treatments. His second patent outlines a "Process for the methyl-4-(dimethylamino)-3,5-dimethoxybenzoate." This compound, referred to as "Methyl 4-dimethylamino-3,5-dimethoxybenzoate," serves as an intermediate in the synthesis of aditoprim, an antibacterially active agent. This innovative process involves substituting bromine atoms from 4-amino-3,5-dibromobenzoic acid with methoxy groups, followed by methylation, showcasing Guerrato's prowess in chemical synthesis.
Career Highlights
Throughout his career, Alfredo Guerrato has collaborated with noteworthy companies, including Proteos S.r.l. and Hoffmann-La Roche Inc. His tenure in these organizations demonstrates his integral role in advancing pharmaceutical innovations. His work has not gone unnoticed, positioning him as a valuable contributor to the scientific community.
Collaborations
Guerrato has worked alongside notable colleagues such as Angelo Signor and Giovanni Signor. Their collaborative efforts have further broadened the scope of research and innovation within the pharmaceutical sector, leading to advancements that benefit public health.
Conclusion
Alfredo Guerrato's innovative spirit and dedication to pharmaceutical development are evident through his contributions to the field. With a solid list of patents and meaningful partnerships with leading companies and collaborators, Guerrato continues to be a pivotal figure in advancing medical therapies. His work reflects the essence of innovation, setting a standard for future inventors in the industry.